| Outgoing Relation(s) |
| dermatologic drug (CHEBI:50177) is a drug (CHEBI:23888) |
| Incoming Relation(s) |
| 5-aminolevulinic acid (CHEBI:17549) has role dermatologic drug (CHEBI:50177) |
| 5-aminolevulinic acid hydrochloride (CHEBI:132969) has role dermatologic drug (CHEBI:50177) |
| adapalene (CHEBI:31174) has role dermatologic drug (CHEBI:50177) |
| afamelanotide (CHEBI:136034) has role dermatologic drug (CHEBI:50177) |
| chloroquine (CHEBI:3638) has role dermatologic drug (CHEBI:50177) |
| cortisol 17-butyrate (CHEBI:31674) has role dermatologic drug (CHEBI:50177) |
| cyclosporin A (CHEBI:4031) has role dermatologic drug (CHEBI:50177) |
| fluticasone propionate (CHEBI:31441) has role dermatologic drug (CHEBI:50177) |
| hydroxychloroquine (CHEBI:5801) has role dermatologic drug (CHEBI:50177) |
| hydroxyzine (CHEBI:5818) has role dermatologic drug (CHEBI:50177) |
| methotrexate (CHEBI:44185) has role dermatologic drug (CHEBI:50177) |
| methoxsalen (CHEBI:18358) has role dermatologic drug (CHEBI:50177) |
| methyl 5-aminolevulinate (CHEBI:724125) has role dermatologic drug (CHEBI:50177) |
| methyl 5-aminolevulinate hydrochloride (CHEBI:60641) has role dermatologic drug (CHEBI:50177) |
| mometasone (CHEBI:6970) has role dermatologic drug (CHEBI:50177) |
| monobenzone (CHEBI:34380) has role dermatologic drug (CHEBI:50177) |
| nonanedioic acid (CHEBI:48131) has role dermatologic drug (CHEBI:50177) |
| oxaceprol (CHEBI:233149) has role dermatologic drug (CHEBI:50177) |
| oxybenzone (CHEBI:34283) has role dermatologic drug (CHEBI:50177) |
| polyhexamethylene biguanide hydrochloride (CHEBI:149534) has role dermatologic drug (CHEBI:50177) |
| porfimer (CHEBI:60652) has role dermatologic drug (CHEBI:50177) |
| porfimer sodium (CHEBI:60773) has role dermatologic drug (CHEBI:50177) |
| potassium permanganate (CHEBI:231501) has role dermatologic drug (CHEBI:50177) |
| resorcinol monoacetate (CHEBI:29672) has role dermatologic drug (CHEBI:50177) |
| ritlecitinib (CHEBI:229233) has role dermatologic drug (CHEBI:50177) |
| ritlecitinib tosylate (CHEBI:229234) has role dermatologic drug (CHEBI:50177) |
| sulfapyridine (CHEBI:132842) has role dermatologic drug (CHEBI:50177) |
| trioxsalen (CHEBI:28329) has role dermatologic drug (CHEBI:50177) |
| antipruritic drug (CHEBI:59683) is a dermatologic drug (CHEBI:50177) |
| antipsoriatic (CHEBI:50748) is a dermatologic drug (CHEBI:50177) |
| antiseborrheic (CHEBI:59010) is a dermatologic drug (CHEBI:50177) |
| keratolytic drug (CHEBI:50176) is a dermatologic drug (CHEBI:50177) |
